Andrew W. Hudacek, Ph.D. - Publications

Affiliations: 
2012 Virology and Gene Therapy College of Medicine - Mayo Clinic 
Area:
Virology Biology, Molecular Biology, Microbiology Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Engeland CE, Bossow S, Hudacek AW, Hoyler B, Förster J, Veinalde R, Jäger D, Cattaneo R, Ungerechts G, Springfeld C. A Tupaia paramyxovirus vector system for targeting and transgene expression. The Journal of General Virology. PMID 28809150 DOI: 10.1099/Jgv.0.000887  0.513
2017 Davis BM, Fensterl V, Lawrence TM, Hudacek AW, Sen GC, Schnell MJ. Ifit2 is a Restriction Factor in Rabies Virus Pathogenicity. Journal of Virology. PMID 28637751 DOI: 10.1128/Jvi.00889-17  0.506
2017 Budaszewski RD, Hudacek A, Sawatsky B, Krämer B, Xiangping Y, Schnell MJ, von Messling V. Inactivated Recombinant Rabies Viruses Displaying the Canine Distemper Virus Glycoproteins Induce Protective Immunity Against Both Pathogens. Journal of Virology. PMID 28148801 DOI: 10.1128/Jvi.02077-16  0.493
2015 Willet M, Kurup D, Papaneri A, Wirblich C, Hooper JW, Kwilas SA, Keshwara R, Hudacek A, Beilfuss S, Rudolph G, Pommerening E, Vos A, Neubert A, Jahrling P, Blaney JE, et al. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. The Journal of Infectious Diseases. PMID 26063224 DOI: 10.1093/Infdis/Jiv251  0.449
2014 Hudacek AW, Al-Saleem FH, Willet M, Eisemann T, Mattis JA, Simpson LL, Schnell MJ. Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo. Molecular Therapy. Methods & Clinical Development. 1: 14046. PMID 26015984 DOI: 10.1038/Mtm.2014.46  0.476
2013 Hudacek AW, Navaratnarajah CK, Cattaneo R. Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins. Cancer Gene Therapy. 20: 109-16. PMID 23306608 DOI: 10.1038/Cgt.2012.92  0.522
2011 Miest TS, Yaiw KC, Frenzke M, Lampe J, Hudacek AW, Springfeld C, von Messling V, Ungerechts G, Cattaneo R. Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1813-20. PMID 21610701 DOI: 10.1038/Mt.2011.92  0.578
2011 Devaux P, Hudacek AW, Hodge G, Reyes-Del Valle J, McChesney MB, Cattaneo R. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. Journal of Virology. 85: 348-56. PMID 20980517 DOI: 10.1128/Jvi.00802-10  0.552
2010 Mossey P, Hudacek A, Das A. Agrobacterium tumefaciens type IV secretion protein VirB3 is an inner membrane protein and requires VirB4, VirB7, and VirB8 for stabilization. Journal of Bacteriology. 192: 2830-8. PMID 20348257 DOI: 10.1128/Jb.01331-09  0.322
2008 Qiao J, Wang H, Kottke T, Diaz RM, Willmon C, Hudacek A, Thompson J, Parato K, Bell J, Naik J, Chester J, Selby P, Harrington K, Melcher A, Vile RG. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Gene Therapy. 15: 604-16. PMID 18305577 DOI: 10.1038/Sj.Gt.3303098  0.395
2005 Simmons HM, Ruis BL, Kapoor M, Hudacek AW, Conklin KF. Identification of NOM1, a nucleolar, eIF4A binding protein encoded within the chromosome 7q36 breakpoint region targeted in cases of pediatric acute myeloid leukemia. Gene. 347: 137-45. PMID 15715967 DOI: 10.1016/J.Gene.2004.12.027  0.335
Show low-probability matches.